Cancer Patients and Oncology Clinical Practice in COVID-19 Pandemic

[1]Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18): 1708–1720.GuanWJNiZYHuYLiangWHOuCQHeJXChina Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in ChinaN Engl J Med2020382181708172010.1056/NEJMoa2002032709281932109013Search in Google Scholar

[2]Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al; COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 Jul 23;136(4):489–500.Al-SamkariHKarp LeafRSDzikWHCarlsonJCTFogertyAEWaheedACOVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infectionBlood2020Jul23136448950010.1182/blood.2020006520737845732492712Search in Google Scholar

[3]G. Curigliano, S. Banerjee, A. Cervantes, M. Garassino, P. Garrido, N. Girard, et al; Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus. Annals of Oncology, https://www.annalsofoncology.org/article/S0923-7534(20)39948-8/pdf.CuriglianoGBanerjeeSCervantesAGarassinoMGarridoPGirardNManaging cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert ConsensusAnnals of Oncologyhttps://www.annalsofoncology.org/article/S0923-7534(20)39948-8/pdf10.1016/j.annonc.2020.07.010783680632745693Search in Google Scholar

[4]Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Glob Oncol. 2020 Apr;6:557–559.DesaiASachdevaSParekhTDesaiRCOVID-19 and Cancer: Lessons From a Pooled Meta-AnalysisJCO Glob Oncol2020Apr655755955910.1200/GO.20.00097719380132250659Search in Google Scholar

[5]Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.EmamiAJavanmardiFPirbonyehNAkbariAPrevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-AnalysisArch Acad Emerg Med2020Mar2481e35eCollection 2020.Search in Google Scholar

[6]Ioannidis G. Pulmonary Large-Cell Neuroendocrine Carcinoma: Therapeutic Challenges and Opportunities. Forum ClinOncol 2020 11(1), 7–21.IoannidisGPulmonary Large-Cell Neuroendocrine Carcinoma: Therapeutic Challenges and OpportunitiesForum ClinOncol202011172110.2478/fco-2019-0010Search in Google Scholar

[7]Ntanasis-Stathopoulos I, Kyriazoglou A, Dimopoulos MA, Gavriatopoulou M. Clinical biomarkers directing the management of patients with colon and lung cancer (beyond on cogene-addicted NSCLC). Forum ClinOncol 2020 11(1), 3–6.Ntanasis-StathopoulosIKyriazoglouADimopoulosMAGavriatopoulouMClinical biomarkers directing the management of patients with colon and lung cancer (beyond on cogene-addicted NSCLC)Forum ClinOncol20201113610.2478/fco-2019-0014Search in Google Scholar

[8]Li B, Perkins S, Phillips S, Martin S, Hsieh S, Shinohara E, et al; A Review of Chemotherapy and Radiotherapy Near the End of Life in Individuals with Metastatic Non-small Cell Lung Cancer. Forum ClinOncol 2020 11(1), 29–36.LiBPerkinsSPhillipsSMartinSHsiehSShinoharaEA Review of Chemotherapy and Radiotherapy Near the End of Life in Individuals with Metastatic Non-small Cell Lung CancerForum ClinOncol2020111293610.2478/fco-2019-0013Search in Google Scholar

[9]Savvari P. Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review. Forum ClinOncol 2020 11(1), 22–28.SavvariPCancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature reviewForum ClinOncol2020111222810.2478/fco-2019-0009Search in Google Scholar

[10]Tsoukalas N, Papakotoulas P, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, et al; Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There? Cancers (Basel). 2020 Jul 15;12(7):E1907.TsoukalasNPapakotoulasPChristopoulouAArdavanisAKoumakisGPapandreouCReal-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?Cancers (Basel)2020Jul15127E190710.3390/cancers12071907740921332679747Search in Google Scholar